Elorac to Present at 23rd World Congress of Dermatology – PharmiWeb.com (press release)
Elorac to Present at 23rd World Congress of DermatologyPharmiWeb.com (press release)Dr. Joel Bernstein Elorac's Executive Chairman is presenting a study of a natural immune modulator which inhibits pro-inflammatory cytokines TNF-a and the JAK-STAT pathway as an adjunct to currently available biologics for treatment of plaque psoriasis.and more »
[monetize id=”1″]
[monetize id=”2″]
Natual Eczema Treatment.mov
XenoPort to Present at the Jefferies 2015 Global Healthcare Conference – Business Wire (press release)
XenoPort to Present at the Jefferies 2015 Global Healthcare ConferenceBusiness Wire (press release)… HORIZANT® (gabapentin enacarbil) Extended-Release Tablets in the United States and developing its novel fumaric acid ester product candidate, XP23829, as a potential treatment for patients with moderate-to-severe chronic plaque-type psoriasis and …and more »
